ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
AstraZeneca
BeOne Medicines
STORM Therapeutics LTD
Genmab
Whitehawk Therapeutics, Inc.
AstraZeneca
Eli Lilly and Company
Jazz Pharmaceuticals
AstraZeneca
Seagen Inc.
Radiopharm Theranostics, Ltd
Arvinas Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
BioNTech SE
NiKang Therapeutics, Inc.
MacroGenics
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
University of Nebraska
Adela, Inc
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Medical College of Wisconsin
Elephas
Elephas
Mayo Clinic
GlaxoSmithKline
Sairopa B.V.
Fate Therapeutics
NextCure, Inc.
Tanabe Pharma America, Inc.
GV20 Therapeutics
Radiopharm Theranostics, Ltd
West China Hospital
Massive Bio, Inc.
Eli Lilly and Company
LigaChem Biosciences, Inc.
Guardant Health, Inc.
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company